“Reversal” ALPPS in patient with hepatocellular carcinoma and liver cirrhosis. First clinical case in Russia
S. E. Voskanyan,
V. S. Rudakov,
M. V. Shabalin,
A. I. Artemyev,
A. N. Bashkov,
I. Yu. Kolyshev,
A. S. Zhurbin,
E. V. Naidenov,
M. V. Popov https://doi.org/10.16931/1995-5464.2021-3-142-148
Abstract
Liver resection in patients with HCC is the treatment of choice. In patients with insufficient future liver remnant (FLR) and compensated liver function performing the Associated Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS) is possible. The classic version of ALPPS consists in ligation of the right branch of the portal vein with transection of the parenchyma and then performing right hepatectomy or right trisegmentectomy. This paper describes the first case in Russia of performing ligation of the left portal branch with transection of the parenchyma and then performing left trisegmentectomy (“reversal” ALPPS) in a patient with HCC and cirrhosis. Reversal ALPPS can be successfully performed in patients with insufficient future liver remnant in well-selected patients.
About the Authors
S. E. Voskanyan
Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency
Russian Federation
Russian Federation
Sergey E. Voskanyan – Doct. of Sci. (Med.), Professor, Corresponding Member of RAS, Deputy Chief Physician for Surgery, Head of the Center of Surgery and Transplantology, Head of the Department of Surgery with Courses of Oncology, Endoscopy, Surgical Pathology, Clinical Transplantology аnd Organ Donation, Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency
23, str. Marshal Novikov, Moscow, 123098
V. S. Rudakov
Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency
Russian Federation
Russian Federation
Vladimir S. Rudakov – Cand. of Sci. (Med.), Surgeon of the Center of Surgery and Transplantology
23, str. Marshal Novikov, Moscow, 123098
Phone: +7-926-523-03-94
M. V. Shabalin
Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency
Russian Federation
Russian Federation
Maxim V. Shabalin – Cand. of Sci. (Med.), Surgeon of the Surgery Department No. 1
23, str. Marshal Novikov, Moscow, 123098
A. I. Artemyev
Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency
Russian Federation
Russian Federation
Aleksey I. Artemyev – Cand. of Sci. (Med.), Head of the Surgery Department No. 2
23, str. Marshal Novikov, Moscow, 123098
A. N. Bashkov
Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency
Russian Federation
Russian Federation
Andrey N. Bashkov – Cand. of Sci. (Med.), Head of the Radiology Department
23, str. Marshal Novikov, Moscow, 123098
I. Yu. Kolyshev
Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency
Russian Federation
Russian Federation
Ilya Yu. Kolyshev – Cand. of Sci. (Med.), Head of the Surgery Department No. 1
23, str. Marshal Novikov, Moscow, 123098
A. S. Zhurbin
Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency
Russian Federation
Russian Federation
Aleksey S. Zhurbin – Junior Researcher at the Laboratory of New Surgical Technologies
23, str. Marshal Novikov, Moscow, 123098
E. V. Naidenov
Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency
Russian Federation
Russian Federation
Evgeny V. Naidenov – Cand. of Sci. (Med.), Surgeon of the Center for Surgery and Transplantology
23, str. Marshal Novikov, Moscow, 123098
M. V. Popov
Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency
Russian Federation
Russian Federation
Maxim V. Popov – Surgeon of Interventional Radiology Departments
23, str. Marshal Novikov, Moscow, 123098
References
1. Strassburg C.P. HCC-associated liver transplantation – where are the limits and what are the new regulations? Visc. Med. 2016; 32 (4): 263–271. https://doi.org/10.1159/000446385
2. Mazzanti R. Hepatocellular carcinoma: where are we? World J. Exp. Med. 2016; 6 (1): 21. https://doi.org/10.5493/wjem.v6.i1.21
3. Voskanyan S.E., Sushkov A.I., Artemiev A.I., Zabezhinsky D.A., Naydenov E.V., Bashkov A.N., Chuchuev E.S., Shabalin M.V., Syutkin V.E. Salvage liver transplantation for hepatocellular carcinoma. Pirogov Russian Journal of Surgery = Khirurgiya. Zhurnal imeni N.I. Pirogova. 2019; 10: 21–28. https://doi.org/10.17116/hirurgia201910121 (In Russian)
4. Maltseva A.P., Syutkin V.E., Kolyshev I.Yu., Rudakov V.S., Svetlakova D.S., Sadikhov Z.O., Udalov Yu.D., Voskanyan S.E. Transplantation in oncology: the future of a multidisciplinary approach. Transplantologiya. The Russian Journal of Transplantation. 2019; 11 (3): 218–233. https://doi.org/10.23873/2074-0506-2019-11-3-218-233 (In Russian)
5. Hackl C., Schlitt H.J., Renner P., Lang S.A. Liver surgery in cirrhosis and portal hypertension. World J. Gastroenterol. 2016; 22 (9): 2725–2735. https://doi.org/10.3748/wjg.v22.i9.2725
6. Itoh S., Yoshizumi T., Shirabe K., Kimura K., Okabe H., Harimoto N., Ikegami T., Uchiyama H., Nishie A., Maehara Y. Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma. Hepatol. Res. Off. J. Jpn. Soc. Hepatol. 2017; 47 (5): 398–404. https://doi.org/10.1111/hepr.12761
7. Crocetti L., Bargellini I., Cioni R. Loco-regional treatment of HCC: current status. Clin. Radiol. 2017; 72 (8): 626–635. https://doi.org/10.1016/j.crad.2017.01.013
8. Poon R.T., Ng I.O., Fan S.T., Lai E.C., Lo C.M., Liu C.L., Wong J. Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J. Clin. Oncol. 2001; 19 (12): 3037–3044. https://doi.org/10.1200/JCO.2001.19.12.3037
9. Pawlik T.M., Esnaola N.F., Vauthey J.N. Surgical treatment of hepatocellular carcinoma: similar long-term results despite geographic variations. Liver Transpl. 2004; 10 (S2): S74–S80. https://doi.org/10.1002/lt.20052
10. Belghiti J., Cortes A., Abdalla E.K., Régimbeau J.M., Prakash K., Durand F., Sommacale D., Dondero F., Lesurtel M., Sauvanet A., Farges O. Resection prior to liver transplantation for hepatocellular carcinoma. Ann. Surg. 2003; 238 (6): 885–893. https://doi.org/10.1097/01.sla.0000098621.74851.65
11. Voskanyan S.E., Chuchuev E.S., Artemiev A.I., Zabezhinsky D.A., Bashkov A.N., Zhurbin A.S., Rudakov V.S., Cholakyan S.V. Associated Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS) in focal liver diseases management. Pirogov Russian Journal of Surgery = Khirurgiya. Zhurnal imeni N.I. Pirogova. 2018; 2: 39–44. https://doi.org/10.17116/hirurgia2018239-44 (In Russian)
12. Linecker M., Björnsson B., Stavrou G.A., Oldhafer K.J., Lurje G., Neumann U., Adam R., Pruvot F.R., Topp S.A., Li J., Capobianco I., Nadalin S., Machado M.A., Voskanyan S., Balci D., Hernandez-Alejandro R., Alvarez F.A., De Santibañes E., Robles-Campos R., Malagó M., de Oliveira M.L., Lesurtel M., Clavien P.A. Risk adjustment in ALPPS is associated with a dramatic decrease in early mortality and morbidity. Ann. Surg. 2017; 266 (5): 779–786. https://doi.org/10.1097/SLA.0000000000002446
13. Linecker M., Kambakamba P., Raptis D.A., Malagó M., Ratti F., Aldrighetti L., Robles-Campos R., Lehwald-Tywuschik N., Knoefel W.T., Balci D., Ardiles V., Santibañes E.D., Truant S., Pruvot F.R., Stavrou G.A., Oldhafer K.J., Voskanyan S., Mahadevappa B., Kozyrin I., Low J.K., Ferrri V., Vicente E., Prachalias A., Pizanias M., Clift A.K., Petrowsky H., Clavien P.A., Frilling A. ALPPS in neuroendocrine liver metastases not amenable for conventional resection – lessons learned from an interim analysis of the International ALPPS Registry. HPB. 2020; 22 (4): 537–544. https://doi.org/10.1016/j.hpb.2019.08.011
14. Voskanyan S.E., Artemiev A.I., Naydenov E.V., Kolyshev I.Yu., Zabezhinsky D.A., Shabalin M.V., Bashkov A.N., Grigorieva O.O., Shcherbin V.V., Zhurbin A.S. ALPPS in overcoming small remnant liver volume in alveolar echinococcosis. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2018; 23 (4): 21–32. https://doi.org/10.16931/1995-5464.2018421-32 (In Russian)
15. Ji R., Zuo S., Qiu S., Li P., Chan A., Sharr W., Lo C.M. Combined Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS) followed by left trisectionectomy and Whipple operation for PNET. Gland. Surg. 2018; 7 (1): 47–53. doi: 10.21037/gs.2017.11.15
16. Galle P.R., Forner A., Llovet J.M., Mazzaferro V., Piscaglia F., Raoul J.L., Schirmacher P., Vilgrain V. EASL clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 2018; 69 (1): 182–236. https://doi.org/10.1016/j.jhep.2018.03.019
17. N’Kontchou G., Nault J.C., Sutter O., Bourcier V., Coderc E., Grando V., Nahon P., Ganne-Carrié N., Diallo A., Sellier N., Seror O. Multibipolar radiofrequency ablation for the treatment of mass-forming and infiltrative hepatocellular carcinomas >5 cm: long-term results. Liver Cancer. 2019; 8 (3): 172–185. https://doi.org/10.1159/000489319
18. Poon R.T., Fan S.T., Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J. Am. Coll. Surg. 2002; 194 (5): 11.
19. Lee I.J., Kim J.W., Han K.H., Kim J.K., Kim K.S., Choi J.S., Park Y.N., Seong J. Concurrent chemoradiotherapy shows long-term survival after conversion from locally advanced to resectable hepatocellular carcinoma. Yonsei Med. J. 2014; 55 (6): 1489. https://doi.org/10.3349/ymj.2014.55.6.1489
20. Chan A., Zhang W.Y., Chok K., Dai J., Ji R., Kwan C., Man N., Poon R., Lo C.M. ALPPS versus portal vein embolization for hepatitis-related hepatocellular carcinoma: a changing paradigm in modulation of future liver remnant before major hepatectomy. Ann. Surg. Published online July 10, 2019. https://doi.org/10.1097/SLA.0000000000003433
21. Ogata S., Belghiti J., Farges O., Varma D., Sibert A., Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br. J. Surg. 2006; 93 (9): 1091–1098. https://doi.org/10.1002/bjs.5341
22. Vennarecci G., Grazi G.L., Santoro R., Ettorre G.M. A room for the ALPPS procedure in patients with HCC. Int. J. Surg. 2015; 13: 90–91. https://doi.org/10.1016/j.ijsu.2014.11.054
23. Frilling A., Md M.M., Md M.L., Lurje G., Capobianco I., Baumgart J., Ratti F., Rauchfuss F., Balci D., Fernandes E., Montalti R., Md R.R., Md B.B., Topp S.A., Fronek J., Liu C., Wahba R., Md C.B., Brunner S.M., Schlitt H.J., Heumann A., Stüben B.O., Izbicki J.R., Bednarsch J., Gringeri E., Fasolo E., Rolinger J., Kristek J., Hernandez-Alejandro R., Schnitzbauer A., Nuessler N., Schön M.R., Md S.V., Petrou A.S., Hahn O., Soejima Y., Md E.V., Md C.C., Adam R., Tomassini F., Troisi R.I., Kantas A., Md K.J.O., Md V.A., Md E.D.S., Malago M., Md P.A.C., Vivarelli M., Settmacher U., Aldrighetti L., Neumann U., Petrowsky H., Cillo U., Lang H., Nadalin S. ALPPS for locally advanced intrahepatic cholangiocarcinoma: did aggressive surgery lead to the oncological benefit? An international multi-center study. Ann. Surg. Oncol. 2020; 27 (5): 1372–1384. https://doi.org/10.1245/s10434-019-08192-z
24. Lang H., Baumgart J., Mittler J. Associated Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Registry: what have we learned? Gut Liver. 2020. February 12. https://doi.org/10.5009/gnl19233
25. Sala S., Ardiles V., Ulla M., Alvarez F., Pekolj J., de Santibañes E. Our initial experience with ALPPS technique: encouraging results. Update Surg. 2012; 64 (3): 167–172. https://doi.org/10.1007/s13304-012-0175-y
26. Obed A., Jarrad A., Bashir A. First left hepatic trisectionectomy including segment one with new Associated Liver Partition and Portal vein ligation with Staged hepatectomy (ALPPS) modification: how to do it? Am. J. Case Rep. 2016; 17: 759–765. https://doi.org/10.12659/ajcr.901265
27. Zattar-Ramos L.C., Bezerra R.O., Siqueira L.T., Marques D.T., Menezes M.R., Herman P., Machado M.A.C., Cerri G.G., Leite C.C. Associating Liver Partition and Portal vein Ligation for Staged hepatectomy (ALPPS) in colorectal liver metastasis: the radiologist’s perspective. Abdom. Radiol. 2016; 41 (11): 2150–2160. https://doi.org/10.1007/s00261-016-0832-6
28. Machado M.A., Surjan R., Basseres T., Makdissi F. Total laparoscopic reversal ALPPS. Ann. Surg. Oncol. 2017; 24 (4): 1048–1049. https://doi.org/10.1245/s10434-016-5620-6
29. Baili E., Tsilimigras D.I., Filippou D., Ioannidis A., Machairas N., Papalampros A., Petrou A., Moris D. Associating liver partition and portal vein ligation for staged hepatectomy in patients with primary liver malignancies: a systematic review of the literature. J. BUON. Published online 2019: 1371–1381.
30. Vennarecci G., Ferraro D., Tudisco A., Levi Sandri G.B., Guglielmo N., Berardi G., Sperduti I., Ettorre G.M. The ALPPS procedure: hepatocellular carcinoma as a main indication. An Italian single-center experience. Update Surg. 2019; 71 (1): 67–75. https://doi.org/10.1007/s13304-018-0596-3
31. Petrowsky H., Györi G., de Oliveira M., Lesurtel M., Clavien P.A. Is partial-ALPPS safer than ALPPS? A single-center experience. Ann. Surg. 2015; 261 (4): e90–92. https://doi.org/10.1097/SLA.0000000000001087
Supplementary files
Review
For citations:
Voskanyan S.E., Rudakov V.S., Shabalin M.V., Artemyev A.I., Bashkov A.N., Kolyshev I.Yu., Zhurbin A.S., Naidenov E.V., Popov M.V. “Reversal” ALPPS in patient with hepatocellular carcinoma and liver cirrhosis. First clinical case in Russia. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2021;26(3):142-148. (In Russ.) https://doi.org/10.16931/1995-5464.2021-3-142-148
Views:
609
Email this article 